Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy
US10596190B2 · kind B2 · utility
10Cited by
2References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 24, 2018 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Sep 30, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a method for eliminating or reducing ototoxicity in patients receiving a platinum based chemotherapeutic. In particular, are methods of reducing ototoxicity in a pediatric patient. The methods described herein include administering an effective amount of sodium thiosulfate to a patient in need thereof to reduce ototoxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.